Medicare could save hundreds of millions of dollars a year if everyone used the cheaper drug, Avastin, instead of the costlier one, Lucentis.
如果每个人都使用更便宜的药物安维汀,而不是更昂贵的雷珠单抗,那么医疗保障每年就可以节省数亿美元。
Avastin currently is approved by the U.S. Food and Drug Administration (FDA) for treating lung and colon cancer, but many doctors use it to treat breast cancer.
阿瓦斯汀目前被美国食品和药物管理局(FDA)批准用于治疗肺癌和结肠癌,但许多医生将其用于治疗乳癌。
Though 10 of the 61 patients who suffered adverse reactions from receiving Avastin injections have recovered, the source and use of the controversial drug is still unknown.
在61名注射了阿瓦斯丁后有不良反应的患者中,虽然有10名已经恢复,但这种有争议的药物的来源和用途仍然处于未知状态。
The Food and Drug Administration has not approved Avastin for use in the eye, and using it rather than the alternative, Lucentis, might carry an additional, although slight, safety risk.
美国食品和药品管理局还没有批准阿瓦斯汀用于眼部治疗,使用它来代替雷珠单抗可能会产生额外的安全风险,尽管这一风险也许很轻微。
Now that the FDA has formally withdrawn the breast cancer indication for Avastin, still more debate is likely to break out.
现在,美国食品和药物管理局正式撤销安维汀治疗的乳腺癌适应症,更多的争论很可能会爆发。
The median survival for patients taking both Avastin and Gemzar was 5.7 months compared with 6.0 months for patients taking Gemzar alone.
吉西他滨合用贝伐单抗的患者中位生存期为5.7个月,而单用吉西他滨者为6个月。
The study researchers assigned 302 patients to receive Avastin and Gemzar and assigned an additional 300 patients to receive Gemzar plus placebo.
该研究中,302名患者接受吉西他滨合用贝伐单抗,300名患者接受吉西他滨和安慰剂。
Avastin is a laboratory-produced molecule known as a monoclonal antibody that mimics the antibodies produced by the body's immune system to defend against harmful substances.
阿瓦斯汀是一种实验室内生产的分子物质,也就是众所周知的单克隆抗体,它能够模拟机体免疫系统产生的抗体来抵御有害物质。
Axitinib was designed to block the creation of blood vessels that feed tumors, similar to Genentech Inc. 's (DNA) Avastin, which is used to treat colorectal and lung cancers.
阿西替尼通过抑制肿瘤血管的生成来起到抗癌的作用,与基因技术公司开发的阿瓦斯丁(该药物用于治疗结肠癌和肺癌)类似。
The most serious side effects associated with Avastin, in some cases resulting in death, are gastrointestinal perforation, wound healing complications, hemorrhage, and blood clots.
阿瓦斯汀最严重的副作用(这些副作用有时可以导致死亡)有胃肠穿孔,伤口愈合并发症,出血和血块形成。
Avastin is the first of this very exciting family of drugs to be approved for lung cancer, and there are several other drugs of this type under development which may prove to work even better.
阿瓦·斯丁是令人振奋的治疗肺癌药物家族中被核准的第一个药物,这个家族中还有一些其它的药物处于开发中,可能证实这些药物的药效会更好。
Avastin is the first of this very exciting family of drugs to be approved for lung cancer, and there are several other drugs of this type under development which may prove to work even better.
阿瓦·斯丁是令人振奋的治疗肺癌药物家族中被核准的第一个药物,这个家族中还有一些其它的药物处于开发中,可能证实这些药物的药效会更好。
应用推荐